Linzy Kirkpatrick, M1, Class of 2023

The iridescent glow of cellophane windows

wraps the building in a blanket of fuchsia and blue,

a playful dance of colors that shift

as I walk past. It’s the first

of many similar days to come.

The corridors whisk me through a

playful maze, a tenuous

barrier between the parents

who wait for news and those of us who

witness it.

Continue reading “Bypass”

A Week In Hell

A Week In Hell

Nathan Stacy, M2, Class of 2022

 My momma was recently diagnosed with cancer of her jaw. She underwent something called a “Flap Surgery”, which removed part of her jaw and replaced it with her leg bone. These are some of my reflections about the experience my family went through during this trying time. I wrote some during this time period, and some afterwards, so the past-tense/present-tense jumps around a little bit.

Continue reading “A Week In Hell”

Hot Take: Health Care Copays are Placing Our Inmates at Risk

Hot Take: Health Care Copays are Placing Our Inmates at Risk

Hebron KelechaClass of 2021

Imagine you work in the kitchen of a correctional facility and your copay for a doctors’ visit costs $5. However, you make a whopping 33 cents an hour.

That is the reality faced by many who are incarcerated in prisons throughout the United States. It is not surprising that most of our prison population is poor when they enter the prison system. Couple this with jobs that pay less than a dollar an hour and fees for accessing health care, and we are laying the foundation for negative health outcomes.

Continue reading “Hot Take: Health Care Copays are Placing Our Inmates at Risk”

The Refocused Health Policy Sandstorm

The Refocused Health Policy Sandstorm

Kate Dixon, M1, Class of 2023

The world of health policy has been consumed with the concern of drug prices – just absolutely and utterly offended by the list price of brand name drugs. How could you not be? When you have drugs like Zolgensma – a brand new drug approved to treat spinal muscular atrophy – running $2.1 million for a single treatment course, it’s pretty easy to throw blame at Big Pharma for the egregious state of the United States’ health care spending. However, when you zoom out and compare drug spending to other expenditures in the vast and complex world of US health care, it becomes pretty clear where the true financial abuse is present – Big Name Hospitals.

Continue reading “The Refocused Health Policy Sandstorm”

The Tumor Board

The Tumor Board

Ben Harstine, M3, Class of 2021

Round the table
Sit one by one
We talk, we vote
Another decision done.
Sixty-five and sick
Tumor load too large
Surgery? No.
Chemo? No.
Radiation No.
It must be time to go on.
A tumor again
One more shot
Hope not lost,
Decisions begin